RCB Bonds PLC, on behalf of Greensleeves Homes Trust, announced a virtual presentation for fixed income investors on October 29, 2025, at 2 PM. The presentation will cover the charity's 2024/25 annual results and future strategy. Presentation slides will be available on the Issuer's and the Charity's website before the meeting, and a recording will be available shortly after for those unable to attend.
On behalf of Greensleeves Homes Trust Limited (the "Charity"), RCB Bonds PLC today announces the Charity will be making a virtual presentation to fixed income investors at 2pm on Wednesday, 29th October 2025 to update them on the 2024/25 annual results and future strategy. To register for the meeting, please contactir@alliacc.com.
Presentation slides will be available on the Issuer's and the Charity's website before the meeting.
If you are unable to join, a recording will be available shortly after the presentation.
For further information, please contact:
RCB Bonds PLC
Briony Maritz
+44 (0)1223 781312
Allia C&C
Mark Glowrey
+44 (0)20 3039 3465
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may contain inaccuracies, outdated information, or subjective interpretations. This content is intended for general informational purposes only and should not be considered professional advice or factual confirmation.
We encourage you to independently verify any information provided, especially if it will be relied upon for making decisions or taking action. Any reliance you place on this material is strictly at your own risk. The AI system that produced this content cannot assess the specifics of individual circumstances, and results may vary based on context and individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.